The Chief of Staff evaluates and determines any additional reason(s) for noncompliance and makes certain that healthcare providers consistently conduct urine drug testing for patients prior to initiating or continuing long-term opioid therapy and periodically thereafter.
Questioned Costs
$0
Funds for Better Use
$0
Recommendation Status
Closed
Source UUID
20-00067-172-4
Recommendation Number
4
Significant Recommendation
Yes